Metraipolis › archive › dc_0f495cc94f80

A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy — Europe PMC PMID:42170190

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42170190
DOI
10.34133/bmr.0328
License (as archived)
solo-consultazione
Archived
2026-11-01T14:08:42.435Z
SHA-256 of the archived text
360425f4f975d045c5975d6a777d75ba028baa474dd876a5e2bddbe8fe485692
Stable URL of this page
https://metraipolis.com/documento/dc_0f495cc94f80

How to cite

A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy — Europe PMC PMID:42170190 — Europe PMC (en), https://europepmc.org/article/MED/42170190 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0f495cc94f80 (Metraipolis archive dc_0f495cc94f80, sha256 360425f4f975d045c5975d6a777d75ba028baa474dd876a5e2bddbe8fe485692)
BibTeX
@misc{dc0f495cc94f80,
  title = {A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy — Europe PMC PMID:42170190},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42170190},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0f495cc94f80; sha256 360425f4f975d045c5975d6a777d75ba028baa474dd876a5e2bddbe8fe485692},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42170190. Agents can read the archived copy with the MCP tool read_document.